Increased circulating GDF15 levels have been consistently associated with adverse outcomes in obesity-related metabolic disorders, heart failure, and atherosclerosis, indicating its diagnostic and prognostic significance and potential [5]. The gene discussed is GDF15; the disease is metabolic disease.